PHAT
PHATHOM PHARMACEUTICALS INC
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-5.68%
Annual Growth
5 years average annual growth
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.
📈 Performance
Price History*
-21.98%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$18.95
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PHAT
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
29 weeks
💵 Average investment amount
$630
⏰ Last time a customer invested in PHAT
141 days
PHAT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
50%
Less than 50k
50%
👶 Age of investors
18 - 25
50%
26 - 34
35 - 90
50%
🙋 Legal gender of investors
Female
50%
Male
50%
Pearlers who invest in PHAT also invest in...
🙌 Performance (5Yr p.a)
36.55%
📊 Share price
$408.46 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
499.46%
📊 Share price
$136.06 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
1027.50%
📊 Share price
$169.24 USD
Want more shares? Try these...
🙌 Performance (5Yr p.a)
-0.86%
📊 Share price